Beijing Winsunny Pharmaceutical CO.LTD - Asset Resilience Ratio
Beijing Winsunny Pharmaceutical CO.LTD (601089) has an Asset Resilience Ratio of 10.89% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's Asset Resilience Ratio has changed over time. See 601089 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Beijing Winsunny Pharmaceutical CO.LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Beijing Winsunny Pharmaceutical CO.LTD worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥511.00 Million | 10.89% |
| Total Liquid Assets | CN¥511.00 Million | 10.89% |
Asset Resilience Insights
- Moderate Liquidity: Beijing Winsunny Pharmaceutical CO.LTD has 10.89% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Beijing Winsunny Pharmaceutical CO.LTD Industry Peers by Asset Resilience Ratio
Compare Beijing Winsunny Pharmaceutical CO.LTD's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
JW Pharmaceutical Corp
KO:001067 |
Drug Manufacturers - Specialty & Generic | 8.17% |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275 |
Drug Manufacturers - Specialty & Generic | 14.80% |
|
Fuan Pharmaceutical Group Co
SHE:300194 |
Drug Manufacturers - Specialty & Generic | 1.34% |
|
DRI Healthcare Trust
TO:DHT-U |
Drug Manufacturers - Specialty & Generic | 13.91% |
|
Hainan Shuangcheng Pharmaceut
SHE:002693 |
Drug Manufacturers - Specialty & Generic | 1.03% |
Annual Asset Resilience Ratio for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing Winsunny Pharmaceutical CO.LTD.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 32.78% | CN¥1.58 Billion ≈ $231.06 Million |
CN¥4.82 Billion ≈ $704.82 Million |
+28.14pp |
| 2021-12-31 | 4.64% | CN¥100.00 Million ≈ $14.63 Million |
CN¥2.15 Billion ≈ $315.08 Million |
+1.73pp |
| 2020-12-31 | 2.91% | CN¥50.00 Million ≈ $7.32 Million |
CN¥1.72 Billion ≈ $251.21 Million |
-- |
About Beijing Winsunny Pharmaceutical CO.LTD
Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical preparations and medical devices China and internationally. The company provides chemical drugs and traditional chinese medicines. Its products used in cardiovascular kind, chronic kidney disease, skin disease, digestive system, diabetes, neuropsychiatric system kind, mental nervous system… Read more